Your browser doesn't support javascript.
loading
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Reddy, Deepika; Peters, Max; Shah, Taimur T; van Son, Marieke; Tanaka, Mariana Bertoncelli; Huber, Philipp M; Lomas, Derek; Rakauskas, Arnas; Miah, Saiful; Eldred-Evans, David; Guillaumier, Stephanie; Hosking-Jervis, Feargus; Engle, Ryan; Dudderidge, Tim; Hindley, Richard G; Emara, Amr; Nigam, Raj; McCartan, Neil; Valerio, Massimo; Afzal, Naveed; Lewi, Henry; Orczyk, Clement; Ogden, Chris; Shergill, Iqbal; Persad, Raj; Virdi, Jaspal; Moore, Caroline M; Arya, Manit; Winkler, Mathias; Emberton, Mark; Ahmed, Hashim U.
Afiliação
  • Reddy D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: Deepika.reddy06@imperial.ac.uk.
  • Peters M; Department of Radiation Oncology, University Medical Centre, Utrecht, The Netherlands.
  • Shah TT; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • van Son M; Department of Radiation Oncology, University Medical Centre, Utrecht, The Netherlands.
  • Tanaka MB; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Huber PM; Urologie St. Anna, Luzern, Switzerland.
  • Lomas D; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Rakauskas A; Urology Department, Lausanne University Hospital, Lausanne, Switzerland.
  • Miah S; Department of Urology, Buckinghamshire Hospitals NHS Trust, Amersham, UK.
  • Eldred-Evans D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Guillaumier S; Department of Surgery and Interventional Sciences, University College London, London, UK; University College Hospital, London, UK.
  • Hosking-Jervis F; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Engle R; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Dudderidge T; Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK.
  • Hindley RG; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; BMI The Hampshire Clinic, Basingstoke, UK.
  • Emara A; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; Department of Urology, Ain Shams University Hospitals, Cairo, Egypt.
  • Nigam R; Department of Urology, Royal Surrey NHS Foundation Trust, UK; BMI Mount Alvernia Hospital, Guildford, UK.
  • McCartan N; Department of Surgery and Interventional Sciences, University College London, London, UK; University College Hospital, London, UK.
  • Valerio M; Urology Department, Lausanne University Hospital, Lausanne, Switzerland.
  • Afzal N; Dorset County Hospital Foundation Trust, Dorchester, UK.
  • Lewi H; Springfield Hospital, Chelmsford, UK.
  • Orczyk C; Department of Surgery and Interventional Sciences, University College London, London, UK; University College Hospital, London, UK.
  • Ogden C; Department of Academic Urology, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Shergill I; Department of Urology, Wrexham Maelor Hospital, Wrexham, UK.
  • Persad R; North Bristol NHS Trust, Westbury on Trym, Bristol, UK.
  • Virdi J; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
  • Moore CM; Department of Surgery and Interventional Sciences, University College London, London, UK; University College Hospital, London, UK; Princess Grace Hospital, London, UK; King Edward VII Hospital, London, UK.
  • Arya M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Department of Surgery and Interventional Sciences, University College London, London, UK; University College Hospital, London, UK.
  • Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Emberton M; Department of Surgery and Interventional Sciences, University College London, London, UK; University College Hospital, London, UK; Princess Grace Hospital, London, UK; King Edward VII Hospital, London, UK.
  • Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; King Edward VII Hospital, London, UK; Cromwell Hospital, London, UK.
Eur Urol ; 81(4): 407-413, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35123819
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ultrassom Focalizado Transretal de Alta Intensidade Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Ultrassom Focalizado Transretal de Alta Intensidade Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article